tiprankstipranks
ImmuPharma Realizes £1.5 Million from Share Sale
Company Announcements

ImmuPharma Realizes £1.5 Million from Share Sale

ImmuPharma (GB:IMM) has released an update.

Don't Miss Our Christmas Offers:

ImmuPharma PLC, the specialist drug discovery and development company, has successfully sold its entire stake of approximately 9.9 million shares in Incanthera plc, generating gross proceeds of around £1.5 million. Despite this sale, ImmuPharma still holds about 7.3 million warrants in Incanthera, exercisable until 6 September 2024. ImmuPharma is known for developing peptide-based therapeutics, focusing on treatments for autoimmune diseases and anti-infectives, with its leading program P140 targeting Lupus and CIDP.

For further insights into GB:IMM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskImmupharma Announces Change in Major Shareholdings
TipRanks UK Auto-Generated NewsdeskImmuPharma Strengthens Financial Team with New Appointment
TipRanks UK Auto-Generated NewsdeskImmuPharma Appoints New Company Secretary for Strategic Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App